- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
KRT19 Antibody rKRT19/799 / Recombinant Cytokeratin 19 Monoclonal Antibody recognizes keratin 19, a type I intermediate filament protein encoded by the human KRT19 gene. Unlike most keratins, KRT19 lacks a conventional C-terminal tail domain, making it structurally distinctive within the cytokeratin family. It participates in the intermediate filament network of epithelial cells, frequently associating with type II keratin 8. These cytoskeletal structures help maintain cellular architecture, distribute mechanical stress, and preserve epithelial integrity during changes in tissue organization.
KRT19 is expressed in numerous simple epithelial tissues, including ductal and glandular structures of the pancreas, liver, breast, and gastrointestinal tract. Its distribution is particularly important in the hepatobiliary system, where cholangiocytes express KRT19 while mature hepatocytes generally lack substantial expression. This distinction makes KRT19 useful for investigating biliary differentiation, hepatic progenitor populations, and changes in epithelial identity during liver injury and regeneration. KRT19 Antibody is therefore relevant to studies examining the relationship between epithelial lineage and tissue remodeling.
In colorectal tissue, cytokeratin 19 is expressed in intestinal epithelial populations and may be retained in colorectal carcinomas. Its expression also occurs in malignancies of the breast, pancreas, lung, thyroid, and other epithelial organs. Although KRT19 is widely used as an epithelial marker, its expression is not restricted to malignant cells, and its diagnostic significance depends on tissue context and complementary markers. The Recombinant Cytokeratin 19 Monoclonal Antibody can support investigations into the distribution of this intermediate filament protein across normal and neoplastic epithelial compartments.
Beyond tissue-based research, KRT19 is studied in relation to epithelial cell plasticity and circulating tumor cell detection. KRT19 transcripts are included in certain molecular assays designed to identify epithelial-derived cells in blood or other biological samples. Proteolytic fragments of cytokeratin 19 have also attracted interest as circulating biomarkers, particularly in lung cancer research. These applications reflect the broader biological significance of keratin expression and turnover during epithelial differentiation and disease.
NSJ Bioreagents provides recombinant antibodies targeting epithelial proteins such as KRT19 for research applications. The recombinant production format of clone rKRT19/799 offers a defined antibody sequence for investigating cytokeratin 19 expression, epithelial organization, and changes in intermediate filament biology.
For additional KRT19 detection options, see our anchor Cytokeratin 19 Antibody KRT19/799 | CK19 | V2678.
Optimal dilution of the KRT19 Antibody rKRT19/799 / Recombinant Cytokeratin 19 Monoclonal Antibody should be determined by the researcher.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
Recombinant human KRT19 protein was used as the immunogen for the recombinant Cytokeratin 19 antibody.
Store the recombinant Cytokeratin 19 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Cytokeratin 19 antibody, CK19 antibody, Keratin 19 antibody, Cytokeratin-19 antibody, Keratin-19 antibody, Type I Cytoskeletal Keratin 19 antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.